169 related articles for article (PubMed ID: 38675703)
1. CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity.
Flavin A; Azizi P; Murataeva N; Yust K; Du W; Ross R; Greig I; Nguyen T; Zhang Y; Mackie K; Straiker A
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675703
[TBL] [Abstract][Full Text] [Related]
2. Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model.
Straiker A; Mitjavila J; Yin D; Gibson A; Mackie K
Pharmacol Res; 2015 Sep; 99():370-6. PubMed ID: 26211948
[TBL] [Abstract][Full Text] [Related]
3. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist.
Atwood BK; Huffman J; Straiker A; Mackie K
Br J Pharmacol; 2010 Jun; 160(3):585-93. PubMed ID: 20100276
[TBL] [Abstract][Full Text] [Related]
4. Enantiomer-specific positive allosteric modulation of CB
Mitjavila J; Yin D; Kulkarni PM; Zanato C; Thakur GA; Ross R; Greig I; Mackie K; Straiker A
Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
[TBL] [Abstract][Full Text] [Related]
5. Translational potential of allosteric modulators targeting the cannabinoid CB
Lu D; Immadi SS; Wu Z; Kendall DA
Acta Pharmacol Sin; 2019 Mar; 40(3):324-335. PubMed ID: 30333554
[TBL] [Abstract][Full Text] [Related]
6. CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists.
Atwood BK; Lee D; Straiker A; Widlanski TS; Mackie K
Eur J Pharmacol; 2011 Jun; 659(2-3):139-45. PubMed ID: 21333643
[TBL] [Abstract][Full Text] [Related]
7. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.
Dodu JC; Moncayo RK; Damaj MI; Schlosburg JE; Akbarali HI; O'Brien LD; Kendall DA; Wu Z; Lu D; Lichtman AH
J Pharmacol Exp Ther; 2022 Jan; 380(1):1-14. PubMed ID: 34625464
[TBL] [Abstract][Full Text] [Related]
8. Modern approaches to the development of synthetic cannabinoid receptor probes.
Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
[TBL] [Abstract][Full Text] [Related]
9. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB
Gamage TF; Farquhar CE; Lefever TW; Thomas BF; Nguyen T; Zhang Y; Wiley JL
Neuropharmacology; 2017 Oct; 125():365-375. PubMed ID: 28803965
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.
Shore DM; Baillie GL; Hurst DH; Navas F; Seltzman HH; Marcu JP; Abood ME; Ross RA; Reggio PH
J Biol Chem; 2014 Feb; 289(9):5828-45. PubMed ID: 24366865
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB
Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J
Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256
[TBL] [Abstract][Full Text] [Related]
12. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
[TBL] [Abstract][Full Text] [Related]
13. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
[TBL] [Abstract][Full Text] [Related]
14. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
[TBL] [Abstract][Full Text] [Related]
15. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
16. CB
Trexler KR; Eckard ML; Kinsey SG
Pharmacol Biochem Behav; 2019 Feb; 177():27-33. PubMed ID: 30597181
[TBL] [Abstract][Full Text] [Related]
17. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
Gamage TF; Ignatowska-Jankowska BM; Wiley JL; Abdelrahman M; Trembleau L; Greig IR; Thakur GA; Tichkule R; Poklis J; Ross RA; Pertwee RG; Lichtman AH
Behav Pharmacol; 2014 Apr; 25(2):182-5. PubMed ID: 24603340
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid
Skolnick P; Crystal R
J Neural Transm (Vienna); 2020 Feb; 127(2):279-286. PubMed ID: 31893308
[TBL] [Abstract][Full Text] [Related]
19. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.
Nguyen T; German N; Decker AM; Li JX; Wiley JL; Thomas BF; Kenakin TP; Zhang Y
Bioorg Med Chem; 2015 May; 23(9):2195-2203. PubMed ID: 25797163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
